发明授权
US08507719B2 Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
有权
（ - ） - 卤化物的结晶固体和无定形形式及其相关方法
- 专利标题： Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto
- 专利标题（中）： （ - ） - 卤化物的结晶固体和无定形形式及其相关方法
-
申请号： US13470142申请日： 2012-05-11
-
公开(公告)号： US08507719B2公开(公告)日： 2013-08-13
- 发明人: Edward D. Daugs , Eric J. Hagen , Jason A. Hanko , David H. Louks
- 申请人： Edward D. Daugs , Eric J. Hagen , Jason A. Hanko , David H. Louks
- 申请人地址： US CA Hayward
- 专利权人： Metabolex, Inc.,DiaTex, Inc.
- 当前专利权人： Metabolex, Inc.,DiaTex, Inc.
- 当前专利权人地址： US CA Hayward
- 代理机构： Hamilton DeSanctis & Cha, LLP
- 代理商 Sam L. Nguyen
- 主分类号： C07C67/02
- IPC分类号： C07C67/02
摘要：
The present invention provides crystalline solid and amorphous forms of (−)-halofenate. The crystalline solid forms may be used in various pharmaceutical compositions, and are particularly effective for the prevention and/or treatment of conditions associated with blood lipid deposition in a mammal, particularly those diseases related to Type 2 diabetes and hyperlipidemia. The invention also relates to a method for preventing or treating Type 2 diabetes and hyperlipidemia in a mammal comprising the step of administering a therapeutically effective amount of crystalline solid and amorphous forms of (−)-halofenate.
公开/授权文献
信息查询
